Peterlabs Holdings Bhd (XKLS:0171) ROCE %: -8.12% (As of Jun. 2025)

What is Peterlabs Holdings Bhd ROCE %?

Peterlabs Holdings Bhd XKLS:0171 46 ROCE % is -8.12% as of Jun. 2025. GuruFocus rates XKLS:0171 with a GF Score™ of 46/100 and a GF Value™ of RM0.20 (Modestly Overvalued). The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Peterlabs Holdings Bhd's annualized ROCE % for the quarter that ended in Jun. 2025 was -8.12%.

Peterlabs Holdings Bhd (XKLS:0171) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Peterlabs Holdings Bhd ROCE % Related Terms

Peterlabs Holdings Bhd ROCE % Historical Data

* Premium members only.

The historical data trend for Peterlabs Holdings Bhd's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Peterlabs Holdings Bhd ROCE % Chart

Peterlabs Holdings Bhd Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

11.64

10.01

13.31

6.27

7.50

Peterlabs Holdings Bhd Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25
ROCE %	Get a 7-Day Free Trial															5.70	6.74	2.99	6.17	-8.12

46GF Score

Peterlabs Holdings Bhd XKLS:0171

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Peterlabs Holdings Bhd ROCE % Calculation

Peterlabs Holdings Bhd's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	6.189	/	( ( (106.225 - 24.945)	+	(118.395 - 34.648) )	/ 2 )
	=	6.189	/	( (81.28	+	83.747)	/ 2 )
	=	6.189	/	82.5135
	=	7.50 %

Peterlabs Holdings Bhd's ROCE % of for the quarter that ended in Jun. 2025 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2025 )		(Q: Mar. 2025 )		(Q: Jun. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2025 )		(Q: Mar. 2025 )		(Q: Jun. 2025 )
	=	-6.652	/	( ( (114.06 - 29.074)	+	(112.152 - 33.199) )	/ 2 )
	=	-6.652	/	( ( 84.986	+	78.953 )	/ 2 )
	=	-6.652	/	81.9695
	=	-8.12 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2025) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of -8.12% mean?

Peterlabs Holdings Bhd (XKLS:0171) has a ROCE % of -8.12% as of Jun. 2025.

Is Peterlabs Holdings Bhd's ROCE % too high?

Peterlabs Holdings Bhd's current ROCE % is -8.12%. Overall, Peterlabs Holdings Bhd has a GF Score™ of 46/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Peterlabs Holdings Bhd's ROCE % compare to ZTS and UTHR?

Peterlabs Holdings Bhd's ROCE % of -8.12% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Drug Manufacturers company?

The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Peterlabs Holdings Bhd's current ROCE % is -8.12%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Peterlabs Holdings Bhd stock overvalued right now?

Based on GuruFocus' analysis, Peterlabs Holdings Bhd (XKLS:0171) is currently considered Modestly Overvalued. The stock's GF Value™ is RM0.20, compared to a current price of RM0.24 — trading 17.5% above its estimated fair value. The current ROCE % is -8.12%. Peterlabs Holdings Bhd's overall GF Score™ is 46/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Peterlabs Holdings Bhd (XKLS:0171), the current ROCE % is -8.12% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Peterlabs Holdings Bhd (XKLS:0171) Overvalued in 2026?

Based on GuruFocus' analysis, Peterlabs Holdings Bhd stock appears to be overvalued. The current stock price of RM0.24 is trading 17.5% above its estimated GF Value™ of RM0.20. GuruFocus considers Peterlabs Holdings Bhd to be Modestly Overvalued.

Key valuation signals for XKLS:0171:

ROCE %: -8.12%
GF Value™: RM0.20 vs. price of RM0.24 (17.5% above fair value)
GF Score™: 46/100 with 6 warning signs

No single metric tells the full story. See the XKLS:0171 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Peterlabs Holdings Bhd Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies XKLS:5278 XKLS:7178 XTER:MRK TSE:4502 XSWX:GALD SHSE:600276 NSE:SUNPHARMA XTAE:TEVA LSE:HLN XSWX:SDZ ZTS HKSE:03692 UTHR VTRS NSE:DIVISLAB OSTO:SOBI TSE:4507 NBIX NSE:TORNTPHARM XPAR:IPN

Address Jalan Nilam 3, Lot 16014 (PT No. 24341), Bandar Nilai Utama, Nilai, NSN, MYS, 71800

Website https://www.peterlabs.com.my

Peterlabs Holdings Bhd is engaged in the manufacturing, distribution, export, and trading of animal health and nutrition products. The Group offers biosecurity and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceuticals, and water-soluble supplements, as well as farm management, technical advisory services, raw material analysis, and feed formulation. Its segments are Manufacturing, which covers the manufacturing and distribution of animal health and nutrition products; Trading, which involves the trading and distribution of animal health and nutrition products and consumer goods, and contributes the majority of its revenue; and Others, which provides investment holding services. The company operates in Malaysia and internationally.

46GF Score

Get the complete analysis for XKLS:0171

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.24

Price

RM0.20

GF Value

View XKLS:0171 Analysis

See ROCE % data for all stocks →